Publications by authors named "Matthijs J Scheltema"

Claim this Profile
E
External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer.
Tessa D Van Bergen, Arthur J A T Braat, Rick Hermsen, Joris G Heetman, Lieke Wever, Matthijs J Scheltema

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy.
Timo F W Soeterik, Joris G Heetman, Rick Hermsen, Lieke Wever, Jules Lavalaye, Matthijs J Scheltema

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.
Bart Geboers, Matthijs J Scheltema, Jason Jung, Joyce Bakker, Florentine E F Timmer

BJU Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.
Bart Geboers, Dennie Meijer, William Counter, Alexandar Blazevski, James Thompson, Matthijs J Scheltema

BJU Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic health record and research; happy marriage or early divorce?
Matthijs J Scheltema, Bas W G van Rhijn

BJU Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.
Yves J L Bodar, Liselotte M S Boevé, Pim J van Leeuwen, Phillippe C Baars, Jakko A Nieuwenhuijzen, Matthijs J Scheltema

BJU Int· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study.
William Gondoputro, Paul Doan, Athos Katelaris, Matthijs J Scheltema, Bart Geboers

Transl Androl Urol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage irreversible electroporation for radio-recurrent prostate cancer.
Matthijs J Scheltema, Athos Katelaris, Phillip D Stricker

Nat Rev Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.
Matthijs J Scheltema, Bart Geboers, Alexandar Blazevski, Paul Doan, Athos Katelaris

BJU Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.
Alexandar Blazevski, Bart Geboers, Matthijs J Scheltema, William Gondoputro, Paul Doan

BJU Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.
Bart Geboers, Matthijs J Scheltema, Alexandar Blazevski, Athos Katelaris, Paul Doan

BJU Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer.
Paul Doan, Athos Katelaris, Matthijs J Scheltema, Andrew Hayen, Amer Amin

BMC Urol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
Sean Ong, Kenneth Chen, Jeremy Grummet, John Yaxley, Matthijs J Scheltema

BJU Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
William Gondoputro, Matthijs J Scheltema, Alexander Blazevski, Paul Doan, James E Thompson

J Nucl Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
Luigi A M J G van Riel, Bart Geboers, Ertunc Kabaktepe, Alexander Blazevski, Daan J Reesink, Matthijs J Scheltema

BJU Int· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study.
Bart Geboers, William Gondoputro, James E Thompson, Daan J Reesink, Luigi A M J G van Riel, Matthijs J Scheltema

Eur Urol Focus· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial.
Paul Doan, Matthijs J Scheltema, Amer Amin, Ron Shnier, Bart Geboers

J Urol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Paul Doan, Matthijs J Scheltema, Amer Amin, Ron Shnier, Bart Geboers

J Urol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.
Alexandar Blazevski, William Gondoputro, Matthijs J Scheltema, Amer Amin, Bart Geboers

BMC Urol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI and CT in the follow-up after irreversible electroporation of small renal masses.
Mara Buijs, Daniel M de Bruin, Peter Gk Wagstaff, Patricia J Zondervan, Matthijs JV Scheltema

Diagn Interv Radiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE).
Alexandar Blazevski, Amer Amin, Matthijs J Scheltema, Anjali Balakrishnan, Anne-Maree Haynes

World J Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Year Freedom from Progression After Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial.
Louise Emmett, Reuben Tang, Rohan Nandurkar, George Hruby, Paul Roach, Matthijs J Scheltema

J Nucl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.
Amer Amin, Matthijs J Scheltema, Ron Shnier, Alexandar Blazevski, Daniel Moses

J Urol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
Amer Amin, Alexandar Blazevski, James Thompson, Matthijs J Scheltema, Michael S Hofman

BJU Int· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
Alexandar Blazevski, Matthijs J Scheltema, Amer Amin, James E Thompson, Nathan Lawrentschuk

BJU Int· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis